tbuckley/cabot-search huggingface dataset:
My Tattoos
Journal: JAMA (1999)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Development and validation of a novel risk score predicting long-term survival in autoimmune hepatitis
Authors: Maaike Biewenga, Verhelst Xavier, Martine Baven-Pronk, Hein Putter, Aad van den Berg, Karin van Nieuwkerk, Henk Van Buuren, Gerd Bouma, Ynte de Boer, Cedric Simoen, Isabelle Colle, Jeoffrey Schouten, Filip Sermon, Christophe Van Steenkiste, Hans Van Vlierberghe, Adriaan Van der Meer, Frederik Nevens, Bart Van Hoek
Journal: Journal of Hepatology (2020)
Withdrawn
Authors: Lisa Beck, Takeshi Yoshida, Anna De Benedetto, Seungshin Rhee, I-Hsin Kuo, Ja- Mie Reese, Gloria David, Lynda Schneider, Amy Paller, Jon Hanifin, Mark Boguniewicz, Kathleen Barnes, Y Leung
Journal: Journal of Allergy and Clinical Immunology (2013)
Optimal criteria for care of patients with cancer
Journal: JAMA (1974)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Expression and hypomethylation of α-fetoprotein gene in unicentric and multicentric human hepatocellular carcinomas
Authors: S Peng
Journal: Hepatology (1993)

The messenger RNA and DNA methylation of the α-fetoprotein gene were studied in 101 resected primary hepatocellular carcinomas, of which 93 were unicentric and 8 were multicentric. Fifty-five were 5 cm or less in diameter (small) and 46 were more than 5 cm in diameter (large). In 48.5% of the cases, we detected α-fetoprotein messenger RNA in hepatocellular carcinomas, more frequently in large (60.9%) than in small (38.2%; p < 0.00001) but not in any of the nontumorous livers. The α-fetoprotein messenger RNA was detected in 83%, 70% and 6.8% of patients with serum α-fetoprotein levels of 320 ng/ml or more, 100 to 319 ng/ml and less than 100 ng/ml, respectively. This finding suggests that α-fetoprotein gene expression in hepatocellular carcinoma contributes to the serum α-fetoprotein elevation in patients with hepatocellular carcinoma. α-Fetoprotein messenger RNA appeared as a major band of 2.4 kb, with two minor species of about 6.5 and 3.6 kb in the hepatocellular carcinoma and the fetal liver. Hypomethylation of the 5′ end of the α-fetoprotein gene was detected in 78.3% of hepatocellular carcinomas expressing α-fetoprotein messenger RNA but infrequently (16.7%) in hepatocellular carcinomas with no detectable α-fetoprotein messenger RNA (p < 0.0003). This finding suggests that hypomethylation at the 5′ region of the gene is associated with α-fetoprotein gene reexpression in hepatocellular carcinoma. The α-fetoprotein gene expression helped to differentiate unicentric from multicentric hepatocellular carcinomas and to identify other hidden α-fetoprotein-secreting hepatocellular carcinomas. The α-fetoprotein gene expression occurred more often in patients younger than 30 yr old (100% vs. 41.2%; p < 0.002), in HBsAg-seropositive patients (53.2% vs. 33.3%; p < 0.03) and in patients with poorly differentiated hepatocellular carcinoma (56% vs. 23.1%; p < 0.003). Patients with unicentric small hepatocellular carcinomas expressing α-fetoprotein messenger RNA or serum α-fetoprotein elevation had a worse 2-yr survival rate than those with neither α-fetoprotein messenger RNA expression nor serum α-fetoprotein elevation (70.6% vs. 94.7%; p < 0.02). We conclude that the α-fetoprotein gene expression in hepatocellular carcinoma possesses biological significance. (HEPATOLOGY 1993;17:35–41.)
Dissecting Popliteal Cyst Is Often Misdiagnosed
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Orbitotomy
Authors: H. Jackson
Journal: BMJ (1947)

lie was a capable sketcher tind pastel painter, and some of his portraits of-his father, mother, and friends are shown.Striking mo-dels illustrate the preparation of antisera in laboratories in France's Oriental possessions, and enlarged photographs and dis- play panels show phically the signifiCanCe 0 is diovenes of micro-organisms and irmuniiy factors.The Wellcome Museum exhibit includes crystals and diagrams showing the foundations of stereochemistry which Pasteur laid.Much of his oijginal apparatus in on view., together with some of his personal possessions.
SENSORY STIMULATION AND THE EPINEPHRIN OUTPUT OF THE SUPRARENALS
Journal: JAMA (1923)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Vitamin H
Authors: Z. A. Leitner
Journal: BMJ (1947)

mented in a very valuable article on the benefits he has observed in skin and other diseases from the use of vitamin K analogue, and recently in " Any Questions " in the Journal (Jan.11, p. 77) your expert stated that vitamin K seemed " to exercise a bene- ficial effect in some cases of perniosis-and this was borne out in the case I am recording where the patient said his cold feet were warmer after taking the drug.May I therefore sug- gest that vitamin K analogue shiould be given a trial in Behcet's syndrome and the result of such treatment recorded.-Iam, etc., Paignton.
Difficult Diagnosis
Authors: William R. Best
Journal: JAMA (1985)

A number of academic physicians from various specialties collaborated in the diagnostic approach to 68 of the most enigmatic clinical presentations that have puzzled the editor, a professor and chairman of family practice. These are arranged in alphabetical order from "Abdominal Pain, Acute" through, among others, "Breast Discharge," "Diarrhea, Chronic," "Failure to Thrive, Infant," "Hyperkalemia and Hypokalemia," "Impotence," "Jaundice," "Pulmonary Nodule, Solitary," "Tinnitus," "Urinary Incontinence," and "Vertigo" to "Weight Loss." Experts in particular fields have thoughtfully considered each topic. They have stressed "high payoff" questions on the medical history, key clues from the physical examination, and some useful branching algorithms. Many useful tables are present. As an example, "Calf Pain" may be the only sign of a potentially serious venous thrombosis, but in most clinical settings it is explained by one of 17 other mostly benign conditions. Which instances call for the "big guns" and which can be simply dismissed?
Feast and Famine: a History of Food and Nutrition in Ireland 1500-1920
Authors: J. Garrow
Journal: Journal of the Royal Society of Medicine (2002)

Bodies Politic: Diseases, Death and Doctors in Britain, 1650±1900How do you picture history?Conventional visual images from the past portray their subjects in an ostensibly realistic manner, but others convey more personal messages from the artist.Such messages may be coded, or transmitted with brutal directness.Individual people, events and places are transformed into stereotypes and metaphors to provide comment on more general social or political situations, usually with strong overtones of parody, protest or subversion.The subjects are to varying degrees remodelled to form caricatures, which range from the comical to the repulsive.Such images are often supplementary to or indeed directly linked with verbal images in the novels, plays, poems and pamphlets of the times and, to this extent, the visual and the verbal cannot be separated.Both provide valuable commentary on the historical contexts in which they are set.Bodies Politic 1 is one of a new series entitled `Picturing History', and British medicine between 1650 and 1900 provides abundant material for Professor Roy Porter to develop several questionsÐnotably, `How did the body and healing practices . . .supply metaphoric commentary upon the wider world of politics and the body politic?'.The emphasis inevitably falls on `the long eighteenth century', on metropolitan rather than provincial practice, and on patients `of the better sort' with time and money at their disposal.Views of the body itself were inherently con¯icting during this periodÐloathsome object or divine handiwork?Thus Gibbon disliked `. . . the naked frankness of Montaigne who exposes all his malady and the operation of each dose of physic on his nerves and bowels', and he was painfully distressed by his own last and unpleasant illnessÐ `varnish the business for the ladies'.Gibbon's less fastidious contemporaries were, however, deeply interested in other people's bodily misfortunes.Publicity was guaranteed for giants, dwarfs and the malformed, and visits to `the Poore lunatiques' at Bethlem hospital provided (according to taste) edi®cation or raucous sport up until 1770.Mary Toft from Godalming, who claimed to give birth to litters of rabbits, was displayed in London in 1726, and was recorded by Hogarth.Rare but profound enjoyment was to be had from botched executions, and the case of Ann Green, hanged in Oxford in 1650, was widely reported.Anthony a Á Wood recorded that `she was carried away to be anatomized by
ERCP training
Authors: D BULLIMORE
Journal: Gut (2001)

Editor,—The leading article “ERCP training —time for change” by Hellier and Morris ((2000) Gut 47:459–60.[OpenUrl][1][FREE Full Text][2]) addresses important issues. Views as to how endoscopic retrograde cholangiopancreatography (ERCP) training should change may vary considerably between those in the average district general hospital (DGH) serving 220 000–250 000, and those in larger units, frequently serving populations of around 500 000. Firstly, those without ERCP training but additional skills elsewhere will soon find themselves a favoured species. What price a skilled ultrasonographer? Advertising recently for a third consultant gastroenterologist to join two who undertook ERCP, we specified that ERCP was a skill not required. We felt an additional … [1]: {openurl}?query=rft.jtitle%253DGut%26rft.stitle%253DGut%26rft.aulast%253DHELLIER%26rft.auinit1%253DM%2BD%26rft.volume%253D47%26rft.issue%253D4%26rft.spage%253D459%26rft.epage%253D460%26rft.atitle%253DERCP%2Btraining---time%2Bfor%2Bchange%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fgut.47.4.459%26rft_id%253Dinfo%253Apmid%252F10986200%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/ijlink?linkType=FULL&journalCode=gutjnl&resid=47/4/459&atom=%2Fgutjnl%2F49%2F4%2F597.1.atom
Correction: Randomised controlled trial of oxytocin alone versus oxytocin and ergometrine in active management of third stage of labour
Journal: BMJ (1993)

An inverse relation between infant birth weight and cardiovascular disease in adulthood has been reported in retrospective cohort studies * Studying the relation between birth weight and blood pressure prospectively from infancy to early childhood may help to elucidate the contribution of early life experiences to disease in later life * This study shows that low and high birthweight infants have different pattems in development of blood pressure from infancy to 4 years of age * At 4 years of age children who had had low or high birth weight had increased blood pressure * These data suggest that the relation between birth weight and adult disease may be explained by different factors in low and high birthweight infants
ANOTHER VICTIM TO OSTEOPATHY.
Journal: JAMA (1901)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
COST OF MEDICAL CARE
Journal: JAMA (1961)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Charity Care Takes Many Forms
Journal: JAMA (1987)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Relationship between Ambient Air Pollution and DNA Damage in Polish Mothers and Newborns
Authors: Robin M. Whyatt, Regina M. Santella, Wieslaw Jedrychowski, Seymour J. Garte, Douglas A. Bell, Ruth Ottman, Alicja Gladek-Yarborough, Greg Cosma, Tie-Lan Young, Thomas B. Cooper, Mary C. Randall, David K. Manchester, Frederica P. Perera
Journal: Environmental Health Perspectives (1998)

Industrialized regions in Poland are characterized by high ambient pollution, including polycyclic aromatic hydrocarbons (PAHs) from coal burning for industry and home heating.In experimental bioassays, certain PAHs are transplacental carcinogens and developmental toxicants.Biologic markers can facilitate evaluation of effects of environmental PAHs on the developing infant.We measured the amount of PAHs bound to DNA (PAH-DNA adducts) in maternal and umbilical white blood cells.The cohort consisted of 70 mothers and newborns from Krakow, Poland, an industrialized city with elevated air pollution.Modulation of adduct levels by genotypes previously linked to risk of lung cancer, specifically glutathione S-transferase Ml (GSTM1) and cytochrome P4501A1 (CYP1A1) Mspl restriction fragment length polymorphism (RFLP), was also investigated.There was a dose-related increase in maternal and newborn adduct levels with ambient pollution at the women's place of residence among subjects who were not employed away from home (p<0.05).Maternal smoking (active and passive) significantly increased maternal (p<0.01)but not newborn adduct levels.Neither CYP1A1 Mspl nor GSTM1 polymorphisms was associated with maternal adducts.However, adducts were significantly higher in newborns heterozygous or homozygous for the CYP1A1 Mspl RFLP compared to newborns without the RFLP (p=0.04).Results indicate that PAH-induced DNA damage in mothers and newborns is increased by ambient air pollution.In the fetus, this damage appears to be enhanced by the CYP1A1 Mspl polymorphism.
Abstract 12513: Poorer Cognitive Function is associated With Objectively Monitored Medication Adherence in Patients With Heart Failure
Authors: Mary A Dolansky, Misty A Hawkins, Julie T Schaefer, Abdus Sattar, John Gunstad, Joseph D Redle, Richard Josephson, Shirley M Moore, Joel W Hughes
Journal: Circulation (2015)

Introduction: Cognitive impairment is prevalent in heart failure (HF); however, its role in HF treatment adherence is unclear. Given the complex polypharmacy in HF treatment, cognitive deficits may be especially important in predicting medication management. Thus, the objective of the current study was to examine the impact of cognitive function on medication adherence among patients with HF using gold standard, objective assessments: neuropsychological testing and electronic pill-box monitoring. Hypothesis: Diminishing cognitive functioning will be associated with poorer medication adherence. Methods: Participants were 372 patients with HF (59.7% male, 68.7±9.7 years) who completed a full neuropsychological battery. Medication adherence was objectively measured for 21 days using the Medisgnals pillbox. Regression analyses tested whether baseline attention, executive function, or memory predicted 21-day medication adherence. Results: In unadjusted analyses, lower scores on all three cognitive domains predicted poorer medication adherence (β = .52-85, p = .001-.009). After adjusting for demographic, clinical, and psychosocial variables, only memory continue to predict medication adherence (β = 0.51, p = .008), whereas executive function trended toward significance (β = 0.24 p = .075) and attention was no longer a predictor (β = 0.34, p = .131). Conclusions: Poorer cognitive function, especially in regards to memory, predicted reduced medication adherence among patients with HF. This effect remained after adjustment for factors known to predict adherence, such as depression, social support, and disease severity level. Our findings emphasize that cognitive deficits are not only prevalent in HF but that they also predict clinical outcomes (i.e., adherence to medication).